1. |
Cases of malaria in the UK increase as use of mefloquine decreases |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 2-2
&NA;,
Preview
|
PDF (861KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
2. |
New era with target-specific agents for RA |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 3-4
Sean Henahan,
Preview
|
PDF (1548KB)
|
|
摘要:
Four new immunomodulatory drugs look set to change the way that patients with rheumatoid arthritis (RA) are treated in the next millennium. This is the beginning of an era of rational, target-specific, treatment of RA, delegates were told at the 1998 Annual Meeting of the American College of Rheumatology [San Diego, US; November 1998]. These drugs provide new treatment options for patients with early and late disease and for patients with moderate to severe RA symptoms. There is considerable excitement among rheumatology researchers regarding the potential of these new treatment strategies.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
3. |
Time for routine supplementation with vitamin D in high-risk groups? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 4-4
&NA;,
Preview
|
PDF (780KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 5-5
&NA;,
Preview
|
PDF (754KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
5. |
Is IFN-&agr;-2b therapy appropriate in mild chronic hepatitis C? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 6-6
&NA;,
Preview
|
PDF (739KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 7-7
&NA;,
Preview
|
PDF (688KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 8-8
&NA;,
Preview
|
PDF (787KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
8. |
Gentle spermicide also inhibits HIV |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 9-10
Robert Carlson,
Preview
|
PDF (1532KB)
|
|
摘要:
The fastest growing segment of the worldwide population at risk for infection with HIV is sexually active women, the majority of whom are of reproductive age. In the US, 80% of women with HIV infection are of reproductive age, and about one-fifth of infected patients acquired the disease via heterosexual transmission. In some countries, especially in sub-Saharan Africa, 90% of patients are infected with HIV through heterosexual transmission. These facts make a mechanism-based female-controlled spermicide and microbicide product highly desirable.*One potential product was described at the combined 16th World Congress of the International Federation of Fertility Societies and the 54th Annual Meeting of the American Society for Reproductive Medicine [San Francisco, US; October 1998].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
9. |
506Upotential in haematological malignancies |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 10-10
&NA;,
Preview
|
PDF (761KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
10. |
Pentafusidepotent activity in HIV infection |
|
Inpharma Weekly,
Volume &NA;,
Issue 1166,
1998,
Page 11-11
&NA;,
Preview
|
PDF (764KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|